Cargando…
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
INTRODUCTION: HIV-1 plasma viral load during treatment can be highly variable. Thus, there is the need to find a measure of cumulative viremia that can be used to assess both the short- and long-term efficacy of highly active antiretroviral therapy (HAART). Here, we validate a measure of cumulative...
Autores principales: | Lima, Viviane D, Sierra-Madero, Juan, Wu, Zunyou, Singer, Joel, Wood, Evan, Hull, Mark W, Harrigan, Paul Richard, Montaner, Julio SG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International AIDS Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013478/ https://www.ncbi.nlm.nih.gov/pubmed/24805184 http://dx.doi.org/10.7448/IAS.17.1.18617 |
Ejemplares similares
-
Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings
por: Lima, Viviane D, et al.
Publicado: (2016) -
Efavirenz and Lopinavir/Ritonavir Alter Cell Cycle Regulation in Lung Cancer
por: Marima, Rahaba, et al.
Publicado: (2020) -
Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
por: Henrivaux, Philippe, et al.
Publicado: (2010) -
Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime
por: Wood, Evan, et al.
Publicado: (2006) -
Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/r Based Antiretroviral Therapy
por: Vesterbacka, Jan, et al.
Publicado: (2013)